Streetbeat News

MGX

Metagenomi Inc.

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

Open

1.85

Mkt cap

65M

Volume

562K

High

1.94

P/E Ratio

-0.73

52-wk high

11.86

Low

1.69

Div yield

N/A

52-wk low

1.61

Levi & Korsinsky has announced a class action lawsuit against Metagenomi, Inc. (NASDAQ:MGX) with a lead plaintiff deadline of November 25, 2024. Investors who suffered losses are encouraged to seek potential recovery under federal securities laws.

Portfolio Pulse from

November 14, 2024 | 6:45 pm

The Schall Law Firm has filed a class action lawsuit against Metagenomi, Inc. (NASDAQ:MGX) for alleged securities fraud related to its IPO. Investors who bought shares in the IPO are urged to join the lawsuit by November 25, 2024.

Portfolio Pulse from

November 14, 2024 | 6:30 pm

Metagenomi, Inc. (NASDAQ:MGX) is facing a lawsuit for securities law violations. Investors who have suffered losses are encouraged to contact Levi & Korsinsky by November 25, 2024, to discuss potential recovery options.

Portfolio Pulse from

November 14, 2024 | 5:45 pm

Metagenomi, Inc. (NASDAQ:MGX) is facing a lawsuit for alleged securities law violations. Investors who have suffered losses are encouraged to contact Levi & Korsinsky for potential recovery options.

Portfolio Pulse from

November 14, 2024 | 5:15 pm

Pomerantz Law Firm has filed a class action lawsuit against Metagenomi, Inc. (NASDAQ:MGX). Investors are advised to contact the firm for more information.

Portfolio Pulse from

November 14, 2024 | 4:45 pm

A class action lawsuit has been filed against Metagenomi, Inc. (NASDAQ:MGX) for potential securities law violations. Investors who suffered losses are encouraged to join the lawsuit by November 25, 2024.

Portfolio Pulse from

November 14, 2024 | 12:45 pm

Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Metagenomi, Inc. (NASDAQ:MGX) and certain officers for alleged securities law violations related to their IPO. The lawsuit covers investors who acquired Metagenomi securities between February 9, 2024, and May 1, 2024.

Portfolio Pulse from

November 14, 2024 | 12:15 pm

A class action lawsuit has been filed against Metagenomi, Inc. (NASDAQ: MGX) by The Gross Law Firm, seeking recovery for investors. Shareholders who purchased MGX shares during the specified class period are encouraged to contact the firm for potential lead plaintiff appointment.

Portfolio Pulse from

November 14, 2024 | 11:00 am

A class action lawsuit has been filed against Metagenomi, Inc. (NASDAQ:MGX) with a deadline of November 25, 2024, for investors to join. The lawsuit is related to potential recovery under federal securities laws.

Portfolio Pulse from

November 14, 2024 | 2:30 am

Levi & Korsinsky has notified investors of Metagenomi, Inc. (NASDAQ:MGX) about a class action lawsuit. Investors who suffered losses can learn about potential recovery under federal securities laws.

Portfolio Pulse from

November 14, 2024 | 2:00 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.